{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:40:12Z","timestamp":1788914412850,"version":"build-2803163510"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T00:00:00Z","timestamp":1391040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087246","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T22:20:19Z","timestamp":1391120419000},"page":"e87246","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B"],"prefix":"10.1371","volume":"9","author":[{"given":"Dithi","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Burkard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Panepinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccm.2009.02.001","article-title":"Overview of antifungal agents","volume":"30","author":"GR Thompson III","year":"2009","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(00)00220-X","article-title":"Standard antifungal therapy in neutropenic patients","volume":"16","author":"M Aoun","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B nephrotoxicity","volume":"49","author":"G Deray","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1128\/AAC.00612-12","article-title":"Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan","volume":"56","author":"S Kagan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"CM Galmarini","year":"2002","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2407-5-4","article-title":"Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy","volume":"5","author":"T Engl","year":"2005","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"P Leyssen","year":"2005","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"QY Wang","year":"2011","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138945007779315524","article-title":"Targeting purine and pyrimidine metabolism in human apicomplexan parasites","volume":"8","author":"JE Hyde","year":"2007","journal-title":"Curr Drug Targets"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar0000509","article-title":"Inhibitors of de novo nucleotide biosynthesis as drugs","volume":"35","author":"RI Christopherson","year":"2002","journal-title":"Accounts of Chemical Research"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.39.2.325","article-title":"Effects of Atovaquone and Other Inhibitors on <italic>Pneumocystis carinii<\/italic> Dihydroorotate Dehydrogenase","volume":"39","author":"I Ittarat","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2174\/156802611796575948","article-title":"Purine and Pyrimidine Pathways as Targets in <italic>Plasmodium falciparum<\/italic>","volume":"11","author":"MB Cassera","year":"2011","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"A Vermes","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","article-title":"In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of <italic>Candida<\/italic> spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods","volume":"46","author":"MA Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"AE Brouwer","year":"2004","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"F Dromer","year":"2008","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1128\/AAC.39.11.2459","article-title":"In vitro determination of optimal antifungal combinations against <italic>Cryptococcus neoformans<\/italic> and <italic>Candida albicans<\/italic>","volume":"39","author":"MA Ghannoum","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"JE Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.12.3.390","article-title":"Comparative study of trichothecin, amphotericin B, and 5-fluorocytosine against <italic>Cryptococcus neoformans<\/italic> in vitro and in vivo","volume":"12","author":"MR Sneller","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/AAC.47.10.3361-3364.2003","article-title":"In vitro interaction of flucytosine with conventional and new antifungals against <italic>Cryptococcus neoformans<\/italic> clinical isolates","volume":"47","author":"P Schwarz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/IAI.60.3.1101-1108.1992","article-title":"Molecular and genetic analysis of URA5 transformants of <italic>Cryptococcus neoformans<\/italic>","volume":"60","author":"A Varma","year":"1992","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1002957","DOI":"10.1371\/journal.ppat.1002957","article-title":"De novo GTP biosynthesis is critical for virulence of the fungal pathogen <italic>Cryptococcus neoformans<\/italic>","volume":"8","author":"CA Morrow","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/MCB.10.9.4538","article-title":"Isolation of the <italic>URA5<\/italic> gene from <italic>Cryptococcus neoformans var. neoformans<\/italic> and its use as a selective marker for transformation","volume":"10","author":"JC Edman","year":"1990","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1099\/jmm.0.004846-0","article-title":"A URA3 null mutant of <italic>Candida albicans<\/italic> (CAI-4) causes oro-oesophageal and gastric candidiasis and is lethal for gnotobiotic, transgenic mice (Tgepsilon26) that are deficient in both natural killer and T cells","volume":"58","author":"E Balish","year":"2009","journal-title":"J Med Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"RL White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method for testing for synergy with any number of agents","volume":"137","author":"MC Berenbaum","year":"1978","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/IAI.00536-07","article-title":"Binding of serum mannan binding lectin to a cell integrity-defective <italic>Cryptococcus neoformans ccr4<\/italic>\u0394 mutant","volume":"75","author":"JC Panepinto","year":"2007","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1251\/bpo68","article-title":"Experimental modulation of capsule size in <italic>Cryptococcus neoformans<\/italic>","volume":"6","author":"O Zaragoza","year":"2004","journal-title":"Biol Proced Online"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1139\/o89-094","article-title":"Pyrimidine biosynthesis in <italic>Saccharomyces cerevisiae<\/italic>: the <italic>ura2<\/italic> cluster gene, its multifunctional enzyme product, and other structural or regulatory genes involved in de novo UMP synthesis","volume":"67","author":"M Denis-Duphil","year":"1989","journal-title":"Biochem Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.micro.62.081307.162753","article-title":"How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in <italic>Cryptococcus neoformans<\/italic>","volume":"63","author":"TL Doering","year":"2009","journal-title":"Annu Rev Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/EC.3.6.1601-1608.2004","article-title":"<italic>UGD1<\/italic>, encoding the <italic>Cryptococcus neoformans<\/italic> UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis","volume":"3","author":"F Moyrand","year":"2004","journal-title":"Eukaryot Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-2958.2002.03059.x","article-title":"Isolation and characterization of capsule structure mutant strains of <italic>Cryptococcus neoformans<\/italic>","volume":"45","author":"F Moyrand","year":"2002","journal-title":"Mol Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"14327","DOI":"10.1073\/pnas.2332326100","article-title":"Apoptosis induced by environmental stresses and amphotericin B in <italic>Candida albicans<\/italic>","volume":"100","author":"AJ Phillips","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3476(76)80624-5","article-title":"Successful treatment of <italic>Candida<\/italic> meningitis with amphotericin B and 5-fluorocytosine in combination","volume":"89","author":"PJ Chesney","year":"1976","journal-title":"J Pediatr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/AAC.4.3.306","article-title":"Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against <italic>Candida albicans<\/italic> in mice","volume":"4","author":"E Titsworth","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/376524","article-title":"Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001","volume":"37","author":"WJ Steinbach","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"<italic>Aspergillus fumigatus<\/italic> and aspergillosis","volume":"12","author":"JP Latge","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1399-3062.1999.010404.x","article-title":"Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century","volume":"1","author":"TJ Walsh","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jac\/4.4.375","article-title":"Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination","volume":"4","author":"BA Lauer","year":"1978","journal-title":"J Antimicrob Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AAC.25.5.560","article-title":"In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against <italic>Aspergillus<\/italic> spp","volume":"25","author":"CE Hughes","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.22.5.763","article-title":"Interactions among Amphotericin-B, 5-Fluorocytosine, Ketoconazole, and Miconazole against Pathogenic Fungi Invitro","volume":"22","author":"FC Odds","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","first-page":"151","article-title":"The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents","volume":"44","author":"VT Andriole","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1369-5274(99)00009-0","article-title":"Novel antifungal drugs","volume":"2","author":"B DiDomenico","year":"1999","journal-title":"Current Opinion in Microbiology"},{"key":"ref45","first-page":"14","article-title":"Emerging fungal infections in immunocompromised patients","volume":"3","author":"CY Low","year":"2011","journal-title":"F1000 Med Rep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","article-title":"Emerging opportunistic yeast infections","volume":"11","author":"MH Miceli","year":"2011","journal-title":"Lancet Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:57:14Z","timestamp":1597442234000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087246"}},"subtitle":[],"editor":[{"given":"Joy","family":"Sturtevant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087246","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,30]]}}}